Characteristics of neuronal lipofuscin in the superior temporal gyrus in Alzheimer's disease do not differ from non-diseased controls: A comparison with disease-related changes in the superior frontal gyrus

Acta Neuropathologica

Volumn 109, Issue 5, 2005, Pages 490-496

  Mountjoy, Christopher Q ^a   Dowson, Jonathan H ^b   Harrington, Charles ^c   Cairns, Mary R ^b   Wilton Cox, Helen ^b  

^a ST ANDREW S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Alzheimer's disease; Lipofuscin; Neocortex

Indexed keywords

LIPOFUSCIN;

ALZHEIMER DISEASE; ARTICLE; AUTOFLUORESCENCE; CELL COUNT; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NEOCORTEX; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PREDICTION; PRIORITY JOURNAL; SAMPLING; SILVER STAINING; TISSUE SECTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; C-REACTIVE PROTEIN; CELL COUNT; CELL SIZE; FRONTAL LOBE; HUMANS; LIPOFUSCIN; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; SENILE PLAQUES; SILVER STAINING; TEMPORAL LOBE;

EID: 21344450962     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-005-0993-9     Document Type: Article

References (58)

1. Arai T, Ikarashi Y, Okamoto K, Kuribara H, Maruyama Y (1997) Memory disturbance and hippocampal degeneration induced by continuous intraventricular infusions of a protease inhibitor leupeptin. Brain Res 754:157-162
2. Bancher C, Grundke-Iqbal I, Iqbal K, Kim KS, Wisniewski HM (1989) Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid β-protein. Neurobiol Aging 10:125-132 10.1016/ 0197-4580(89)90021-3
3. Beyreuther K, Beer J, Hilbich C, Dyrks T, Fisher P, Weidemann A, Maulthaup G, Cramer M, Salbaum JM, Wehr S, Martins R, Sims G, Rumble B, Fuller S, Hutchinson L, Masters CL (1988) Molecular pathology of amyloid deposition in Alzheimer's disease. In: Henderson AS, Henderson JH (eds) Etiology of dementia of Alzheimer's type. Wiley, New York, pp 125-134
4. Bondareff W (1983) Age and Alzheimer's disease. Lancet I:1447
5. Bondareff W (1994) Subtypes of Alzheimer's disease. In: Burns A, Levy R (eds) Dementia. Chapman and Hall, London, pp 101-113
6. Braak E, Griffing K, Arai K, Bohl J, Bratzke H, Braak H (1999) Neuropathology of Alzheimer's disease: What is new since A. Alzheimer. Eur Arch Psychiatry Clin Neurosci 249 (Suppl 3):14-22
7. Braak H, Braak E (1986) Ratio of pyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease. Prog Brain Res 70:185-212
8. Braak H, Braak E (1998) Evolution of neuronal changes in the course of Alzheimer's disease. J Neurol Transm Suppl 53:127-140
9. Brizzee KR, Harkin JC, Ordy JM, Kaack B (1975) Accummulation and distribution of lipofuscin, amyloid and senile plaques in the aging nervous system. In: Brody H, Harman D, Ordy JM (eds) Clinical morphologic, and neurochemical aspects in the aging central nervous system, vol 1. Raven Press, New York, pp 39-78
10. Brunk UT, Terman A (2002) Lipofuscin: Mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med 33:611-619 10.1016/S0891-5849(02)00959-0
11. Brunk UT, Terman A (2002) The mitochondrial-lysosomal axis theory of ageing: Accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 269:1996-2002
12. Cataldo AM, Nixon RA (1990) Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci USA 87:3861-3865
13. Cataldo AM, Paskevich PA, Kominami E, Nixon RA (1991) Lysosomal hydrolases of different classes are abnormally distributed in brains of patient with Alzheimer's disease. Proc Natl Acad Sci USA 88:10998-11002
14. D'Andrea MR, Nagele RG, Gumula NA, Reiser PA, Polkovitch DA, Hertzog BM, Andrade-Gordon P (2002) Lipofuscin and Aβ42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains. Neurosci Lett 323:45-49
15. Deng G, Su JH, Cotman CW (1996) Gene expression of Alzheimer-associated presenilin-2 in the frontal cortex of Alzheimer and aged control brain. FEBS Lett 394:17-20
16. Ditaranto-Desimone K, Saito M, Tekirian TL, Saito M, Berg M, Dubowchick G, Soreghan B, Thomas S, Marks N, Young AJ (2003) Neuronal endosomal/ lysososmal membrane destabilisation activates caspases and induces abnormal accumulation of the lipid secondary messenger ceramide. Brain Res Bull 59:523-531
17. Ditaranto K, Tekirian TL, Yang AJ (2001) Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis 8:19-31
18. Drach LM, Bohl J, Wach S, Schlotze W, Goebel HH (1998) Reduced intraneuronal lipofuscin content in dementia with Lewy bodies compared with Alzheimer's disease and controls. Dement Geriatr Cogn Disord 9:1-5
19. Dowson JH (1982) The evaluation of autofluorescence emission spectra derived from neuronal lipopigment. J Microsc 128:261-270
20. Dowson JH, Mountjoy CQ, Cairns MR, Wilton-Cox H (1992) Changes in intraneuronal lipopigment in Alzheimer's disease. Neurobiol Aging 13:493-500
21. Dowson JH, Mountjoy CQ, Cairns MR, Wilton-Cox H (1995) Alzheimer's disease: Distribution of changes in intraneuronal lipopigment in the frontal cortex. Dementia 6:334-342
22. Dowson JH, Mountjoy CQ, Cairns MR, Wilton-Cox H, Bondareff W (1998) Lipopigment changes in Purkinje cells in Alzheimer's disease. J Alzheimers Dis 1:71-79
23. Drach LM, Bohl J, Goebel H-H (1994) The lipofuscin content of nerve cells of the inferior olivary nucleus in Alzheimer's disease. Dementia 5:234-239
24. Duyckaerts C, Delaere P, Hauw J-J (1990) Rating of the lesions in senile dementia of the Alzheimer type: Concordance between laboratories. A European multicentre study under the auspices of EURAGE. J Neurol Sci 97:295-323
25. Duyckaerts C, Hauw J-J, Basternaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P (1986) Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (Berl) 70:249-256
26. Duyckaerts C, Hauw J-J, Piette F, Rainsard C, Poulain V, Berthaux P, Escourolle R (1985) Cortical atrophy in senile dementia of the Alzheimer type is mainly due to a decrease in cortical length. Acta Neuropathol (Berl) 66:72-74
27. Funato H, Yoshimura M, Kusui K, Tamoaka A, Ishikawa K, Ohkoshi N, Namekata K, Okeda R, Ihara Y (1998) Quantitation of amyloid β-protein (Aβ) in the cortex during ageing and in Alzheimer's disease. Am J Pathol 152:983-992
28. Glees P, Hasan M (1976) Lipofuscin in neuronal aging and diseases. Norm Pathol Anat (Stuttg) 32:1-68
29. Goebel HH, Braak H (1989) Adult neuronal ceroid-lipofuscinosis. Clin Neuropathol 8:109-119
30. Harrington CR, Wischik CM (1994) Molecular pathobiology of Alzheimer's disease. In: Burns A, Levy R (eds) Dementia. Chapman and Hall, London, pp 210-238
31. Heckers S, Geula C, Mesulam M-M (1992) Acetyl-cholinesterase-rich pyramidal neurons in Alzheimer's disease. Neurobiol Aging 12:455-460
32. Hof PR, Morrison JH (1991) Neocortical neuronal subpopulation labelled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp Neurol 111:293-301
33. Horie K, Miyata T, Yasuda T, Takeda A, Yasuda Y, Maeda K, Sobue G, Kurokawa K (1997) Immunohistochemical localisation of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem Biophys Res Commum 236:327-332
34. Ikeda K, Akiyama H, Arai T, Kondo H, Haga C, Iritani S, Tsuchiya K (1998) Alz-50/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains. Neursoci Lett 258:113-116
35. Joachim CL, Morris JH, Selkoe DJ (1988) Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases. Neurology 24:50-56
36. Khatchaturian Z (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105
37. Lantos PL, Cairns NJ (1994) The neuropathology of Alzheimer's disease. In: Burns A, Levy R (eds) Dementia. Chapman and Hall, London, pp 185-207
38. Lewis DA, Higgins GA, Young WG, Goldgaber D, Gajdusek DC, Wilson MC, Morrison JH (1988) Distribution of precursor amyloid-β-protein messenger RNA in human cerebral cortex: Relationship to neurofibrillary tangles and neuritic plaques. Proc Natl Acad Sci USA 85:1691-1695
39. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspice of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944 1:STN:280:BiuB2cnis1M%3D
40. Mirra SS, Heyman A, McKell D (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardisation of the neuropathological assessment of Alzheimer's disease. Neurology 41:479-486 1:STN:280:By6C1cjitVc%3D
41. Mountjoy CQ, Roth M, Evans NJR, Evans HM (1983) Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging 4:1-11
42. Nakamura Y, Takeda M, Suzuki H (1991) Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease. Neurosci Lett 130:195-198
43. Newell KL, Hyman BT, Growdon JH, Headley-Whyte ET (1999) Application of the National Institute on Ageing (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer's disease. J Neuropathol Exp Neurol 58:1147-1155
44. Nixon RS, Cataldo AM (1994) Free radicals, proteolysis, and the degeneration of neurons in Alzheimer's disease: How essential is the β-amyloid link? Neurobiol Aging 15:463-469
45. +. SPSS Inc, Chicago
46. Papasozomenos S (1999) Tau protein immunoreactivity in dementia of the Alzheimer type. Lab Invest 60:123-137
47. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci USA 82:4531-4534
48. Porta EA (2002) Pigments in ageing: An overview. Ann N Y Acad Sci 959:57-65
49. Pratico D, Uryu K, Leight S, Trojanowski JQ, Lee VM-Y (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21:4183-4187
50. Rogers J, Morrison JH (1985) Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer's disease. J Neurosci 5:2801-2808
51. Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M (1984) Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J 288:961-964
52. Snow AD, Mar H, Nochlin D, Sekiguchi RT, Kimata K, Koike Y, Wright TN (1990) Early accumulation of heparan sulphate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 137:1253-1270
53. Stojanovic A, Roher AE, Ball MJ (1994) Quantitative analysis of lipofuscin and neurofibrillary tangles in the hippocampal neurons of Alzheimer disease brains. Dementia 5:229-233
54. Swaab DF, Hofman MA, Lucassen PJ, Salehi A, Vylings HBM (1994) Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease. Neurobiol Aging 15:369-371
55. Taylor JP, Hardy J, Fischbeck KH (2002) Toxic proteins in neurodegenerative disease. Science 296:1991-1995
56. Terry RD, Pack A, De Teresa R, Schechter R, Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10:184-192
57. Vogt BA, Van Horsen GW, Vogt LJ (1990) Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease. Acta Neuropathol 80:581-589
58. Wisniewski HM, Wen GY (1988) Lipopigment in the aging brain. Am J Med Genet (Suppl) 5:183-191